News

R-Pharm to extend Russian/CIS territory by adding Turkey • EUR 1.0 million upfront payment • EUR 3.0 million in future milestone payments...
read more...
November 27
On November 21-22, 2013 R-Pharm Group held a kick-off meeting for the researchers involved into clinical trials (Phase III) of Narlaprevir,...
read more...
November 22
Alexey Repik, Chairman of JSC R-Pharm and Co-Chairman of All-Russia Business Association “Delovaya Rossiya”, took part in the IX meeting of...
read more...
November 13
The Experts Council dedicated to the development of the TD1792 heterodimer antibiotic took place as part of the IDWeek International...
read more...
November 2
• PAION will receive EUR 1 million upfront payment • EUR 3.0 million regulatory and commercial milestone payments • Exclusive license grant...
read more...
October 30
- Abbott and R-Pharm has signed the distribution agreement for sale and promotion of Abbott’s FreeStyle Optium Blood Glucose Monitoring...
read more...
October 23
Moscow, Russian Federation – October 8, 2013; Mallinckrodt Pharmaceuticals, CJSC “R-Pharm” and its affiliate company, CJSC “ORTAT” are...
read more...
October 8
The Camp took place on September 21-28 in “Krasny Holm” recreational complex located in Yaroslavl region. Over 100 fifth year students from...
read more...
September 28
MOSCOW (Sept. 24, 2013) – Amgen and R-Pharm today announced a new licensing and collaboration agreement to develop and commercialize AMG...
read more...
September 24
The forum took place on September 20 in Saint Petersburg; All-Russia Business Association “Delovaya Rossiya” (“Business Russia”) was among...
read more...
September 20